The stock option has an exercise price of
About
Company Contact:
Director, Head of Corporate Communications and Investor Relations
hcollins@tayshagtx.com
Media Contact:
carolyn.hawley@canalecomm.com
Source:
2024 GlobeNewswire, Inc., source
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.83 USD | -4.01% | +23.80% | +118.93% |
May. 14 | Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours | MT |
May. 14 | Transcript : Taysha Gene Therapies, Inc., Q1 2024 Earnings Call, May 14, 2024 |
The stock option has an exercise price of
About
Company Contact:
Director, Head of Corporate Communications and Investor Relations
hcollins@tayshagtx.com
Media Contact:
carolyn.hawley@canalecomm.com
Source:
2024 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
+118.93% | 746M | |
+58.94% | 59.34B | |
+43.17% | 40.24B | |
-5.23% | 39.88B | |
-5.56% | 28.55B | |
+15.66% | 27.26B | |
-21.17% | 19.23B | |
+33.57% | 12.61B | |
+2.40% | 12.49B | |
+26.57% | 12.28B |